DOJ Enforcement of Clinical Laboratories: Trends from Q4 2025

Start
The final quarter of 2025 saw continued enforcement actions against clinical labs and other related healthcare entities. The Office of Inspector General (OIG) and Department of Justice (DOJ) heavily focused on False Claims Act (FCA) violations, Anti-Kickback Statute (AKS) violations, conspiracies, and COVID-19 related fraud. Below are highlights of these enforcement actions….
By: Robinson+Cole Health Law Diagnosis
Previous Story

Global Privacy Watchlist

Next Story

Automated Vehicles in the UK: What’s coming down the road in 2026?